ATE518543T1 - Topisches hautmittel mit modifiziertem ton zur verhinderung von entzündungen - Google Patents

Topisches hautmittel mit modifiziertem ton zur verhinderung von entzündungen

Info

Publication number
ATE518543T1
ATE518543T1 AT05811402T AT05811402T ATE518543T1 AT E518543 T1 ATE518543 T1 AT E518543T1 AT 05811402 T AT05811402 T AT 05811402T AT 05811402 T AT05811402 T AT 05811402T AT E518543 T1 ATE518543 T1 AT E518543T1
Authority
AT
Austria
Prior art keywords
modified clay
topical skin
prevent inflammation
skin remedy
skin
Prior art date
Application number
AT05811402T
Other languages
English (en)
Inventor
Yasuhiro Ohara
Masashi Suzuki
Norikazu Takano
Shunpei Mitsuyama
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Application granted granted Critical
Publication of ATE518543T1 publication Critical patent/ATE518543T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05811402T 2004-12-22 2005-11-25 Topisches hautmittel mit modifiziertem ton zur verhinderung von entzündungen ATE518543T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004371895 2004-12-22
PCT/JP2005/022139 WO2006067945A1 (en) 2004-12-22 2005-11-25 External skin agent comprising modified clay for preventing inflammation

Publications (1)

Publication Number Publication Date
ATE518543T1 true ATE518543T1 (de) 2011-08-15

Family

ID=35999539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05811402T ATE518543T1 (de) 2004-12-22 2005-11-25 Topisches hautmittel mit modifiziertem ton zur verhinderung von entzündungen

Country Status (11)

Country Link
US (2) US8741323B2 (de)
EP (1) EP1846010B1 (de)
JP (1) JP5044402B2 (de)
KR (1) KR101228862B1 (de)
CN (1) CN101084000B (de)
AT (1) ATE518543T1 (de)
AU (2) AU2005317496B2 (de)
CA (1) CA2592068C (de)
ES (2) ES2371026T3 (de)
TW (1) TWI422393B (de)
WO (1) WO2006067945A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2371026T3 (es) * 2001-10-19 2011-12-26 Atritech, Inc. Dispositivo de oclusión ajustable en la orejuela auricular izquierda.
US20080026079A1 (en) * 2006-06-27 2008-01-31 Texas Enterosorbents Inc. Calcium aluminosilicate pharmaceutical
JP5695289B2 (ja) * 2007-08-02 2015-04-01 ポーラ化成工業株式会社 乳化剤形の皮膚外用剤
BRPI1008815A2 (pt) * 2009-02-05 2018-02-14 Digna Biotech, S.L composições farmacêuticas compreendendo peptídeos inibidores de tgf-beta1
CN105816498A (zh) 2009-04-27 2016-08-03 玫琳凯有限公司 植物性抗痤疮制剂
JP5165736B2 (ja) * 2010-08-06 2013-03-21 株式会社シャネル化粧品技術開発研究所 トラネキサム酸エステルの生理学的に許容される塩を含む外用組成物の製造方法
WO2013059827A1 (en) 2011-10-20 2013-04-25 Salient Pharmaceuticals, Inc. Methods and compositions for treating mucositis
WO2013096485A1 (en) 2011-12-19 2013-06-27 Mary Kay Inc. Combination of plant extracts to improve skin tone
EP3116469B1 (de) 2014-03-10 2018-10-03 Mary Kay, Inc. Hautaufhellungszubereitungen
CN104983604A (zh) * 2015-06-30 2015-10-21 江苏奇力康皮肤药业有限公司 去油保湿洁面乳及其制备方法
US20190125734A1 (en) * 2016-05-09 2019-05-02 Nanoegg Research Laboratories, Inc. Composition for treating or preventing atopic dermatitis
EP3897530B1 (de) 2018-12-21 2026-05-20 Unilever IP Holdings B.V. Antimikrobielle zusammensetzungen mit modifiziertem ton und nichtionischen triblock copolymeren
KR102077047B1 (ko) * 2019-08-09 2020-02-14 한국지질자원연구원 벤토나이트를 유효성분으로 포함하는 화장료 조성물
CN115589946A (zh) * 2022-10-18 2023-01-13 安赛搏（重庆）生物技术有限公司（Cn） 一种沙漠蔷薇叶愈伤组织提取物的制备方法及其应用
WO2025208003A1 (en) * 2024-03-29 2025-10-02 Sen-Jam Pharmaceutical Inc. Pharmaceutical formulations and manufacturing processes

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0047804A1 (de) * 1980-09-15 1982-03-24 Unilever Plc Wasser-in-Öl-Emulsionen und Verfahren zu deren Herstellung
JPS61113646A (ja) * 1984-11-08 1986-05-31 Shiseido Co Ltd シリコンオイルを含むゲル組成物
JPS61114721A (ja) * 1984-11-08 1986-06-02 Shiseido Co Ltd 乳化剤組成物
JPS61129033A (ja) 1984-11-28 1986-06-17 Shiseido Co Ltd 乳化剤組成物
JPS61212321A (ja) 1985-03-15 1986-09-20 Shiseido Co Ltd 乳化剤組成物
JPS6254759A (ja) * 1985-09-03 1987-03-10 Shiseido Co Ltd シリコンオイルを含むゲル組成物
JPS62216635A (ja) 1986-03-18 1987-09-24 Shiseido Co Ltd 油中水および多価アルコ−ル型乳化組成物
US5036108A (en) * 1988-12-14 1991-07-30 Kao Corporation Water-in-oil emulsion cosmetic
US5422361A (en) * 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
JPH0570336A (ja) * 1991-09-13 1993-03-23 Kose Corp 油中水型乳化化粧料
JPH08217695A (ja) 1995-02-10 1996-08-27 Pola Chem Ind Inc 皮膚外用剤
CN1103585C (zh) * 1995-03-14 2003-03-26 普罗克特和甘保尔公司 分散的蒙脱石粘土作为水包油稳定剂用于洁肤液体组合物
EP0876159A1 (de) * 1996-01-23 1998-11-11 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Zusammensetzung zur behandlung von hautkrankheiten und verfahren zu seiner herstellung
US5665367A (en) * 1996-09-27 1997-09-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing naringenin and/or quercetin and a retinoid
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6148264A (en) * 1998-07-06 2000-11-14 Exxonmobil Upstream Research Company Method for removing seismic noise caused by external activity
CO5150167A1 (es) 1998-12-04 2002-04-29 Johnson & Johnson Consumer Composiciones para el cuidado de la piel, que contienen sales de cinc y retinoides
KR100371491B1 (ko) 1999-07-27 2003-02-07 주식회사 두산 피부 보호용 크림조성물
US6855342B2 (en) 2000-06-30 2005-02-15 Medicis Pharmaceutical Corporation Compositions and methods for high sorption of skin materials and delivery of sulfur
JP2002047129A (ja) * 2000-08-02 2002-02-12 Kose Corp 乳化化粧料
DE10114382A1 (de) * 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
US6923975B2 (en) * 2001-05-17 2005-08-02 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method of enhanced moisture or reduced drying using wet-skin treatment compositions
JP2003026608A (ja) * 2001-07-10 2003-01-29 Nof Corp 皮膚外用剤組成物
JP2003026529A (ja) 2001-07-12 2003-01-29 Kose Corp 油性化粧料
JP4936618B2 (ja) 2001-09-21 2012-05-23 株式会社ノエビア 微細エマルション組成物
FR2830195B1 (fr) 2001-10-03 2004-10-22 Sederma Sa Compositions cosmetiques et dermopharmaceutiques pour les peaux a tendance acneique
ES2371026T3 (es) * 2001-10-19 2011-12-26 Atritech, Inc. Dispositivo de oclusión ajustable en la orejuela auricular izquierda.
JP2003160462A (ja) 2001-11-21 2003-06-03 Pola Chem Ind Inc バリアー機能を有する機能性皮膚外用剤
JP2003192525A (ja) * 2001-12-27 2003-07-09 Pola Chem Ind Inc 疑似生体性ポリマー及びスフィンゴシン類似物質を含有する皮膚外用剤
JP2004075661A (ja) * 2002-06-18 2004-03-11 Shiseido Co Ltd 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法
JP4024189B2 (ja) * 2003-07-17 2007-12-19 ポーラ化成工業株式会社 保湿用の化粧料
WO2005039517A1 (en) * 2003-10-21 2005-05-06 Unilever Plc Hair conditioning compositions
JP4090054B2 (ja) * 2004-01-14 2008-05-28 株式会社資生堂 皮膚外用医薬製剤

Also Published As

Publication number Publication date
US20140235577A1 (en) 2014-08-21
AU2005317496A1 (en) 2006-06-29
KR20070092296A (ko) 2007-09-12
EP1846010B1 (de) 2011-08-03
CN101084000B (zh) 2011-11-16
US8741323B2 (en) 2014-06-03
ES2371026T3 (es) 2011-12-26
TW200637584A (en) 2006-11-01
JP5044402B2 (ja) 2012-10-10
EP1846010A1 (de) 2007-10-24
AU2011200366B2 (en) 2011-10-13
CA2592068A1 (en) 2006-06-29
AU2005317496B2 (en) 2010-10-28
US20150306118A9 (en) 2015-10-29
JP2008524115A (ja) 2008-07-10
HK1114556A1 (en) 2008-11-07
US20100003210A1 (en) 2010-01-07
CA2592068C (en) 2015-01-13
AU2011200366A1 (en) 2011-02-17
TWI422393B (zh) 2014-01-11
KR101228862B1 (ko) 2013-02-05
US20150051170A2 (en) 2015-02-19
CN101084000A (zh) 2007-12-05
WO2006067945A1 (en) 2006-06-29
ES2371027T3 (es) 2011-12-26

Similar Documents

Publication Publication Date Title
EA200701661A1 (ru) Композиция активного вещества
TW200637584A (en) External skin agent for preventing inflammation
EA200870019A1 (ru) Лактамовые соединения и способы их применения
CY1107467T1 (el) Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων
ATE355106T1 (de) Verbesserte kosmetische zusammensetzung mit vitamin b3, vitamin b6 und einer organischen säure
ATE430589T1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
WO2004089396A3 (en) Anti-fungal peptidomimetics
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
NO20091976L (no) Nye forbindelser
ATE478867T1 (de) Substituierte quinazolinone verbindungen
EA200600065A3 (ru) Гидрофобные композиционные и сыпучие материалы, их применение
MA29682B1 (fr) Combinaison d'agents actifs fongicides synergiques
DK1567570T3 (da) Modificerede polymere flokkuleringsmidler med forbedrede ydelseskarakteristika
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
WO2009057664A1 (ja) 抗体及びその利用
EA200401341A1 (ru) Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания
DE60234527D1 (de) Polymerzusammensetzung enthaltend ein polymer mit polymergradient morphologie
EP1945035A4 (de) Verwendung von prolinen zur wachstums- oder ertragserhöhung
NO20031648D0 (no) Farmasöytiske lösninger av modafinilforbindelser
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
EP4024506A4 (de) Positive elektrode, elektrochemische vorrichtung und elektronische vorrichtung damit
MA29485B1 (fr) Motilides
ATE485049T1 (de) Physiologisch aktive zusammensetzung gegen diabetes
CY1108042T1 (el) Θεραπεια εντερικων καταστασεων με ν-2,3,3-τετραμεθυλδικυκλο[2.2.1]επταν-2-αμινη
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties